However, our observations are consistent with those reported by Storti et al. who performed bulk microarray profiling of CD138-selected cells from patient BM and similarly found that the transcriptomic profile of myeloma cells remains substantially unchanged throughout progression10. This evidence concerns the gene SDC1 and plasma cell myeloma.